Abstract
We used a mathematical model to evaluate the impact of mass testing in the control of SARS-CoV-2. Conditions required to control a quickly growing epidemic with mass testing appear impossible to achieve. Mass testing should therefore not be seen as a silver bullet that will ensure other control measures can be removed. Even under a set of optimistic assumptions, this strategy is most relevant when epidemic growth remains limited, thanks to a combination of interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge financial support from the Investissement d'Avenir program, the Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), Santé Publique France, the INCEPTION project (PIA/ANR-16-CONV-0005), and the European Union's Horizon 2020 research and innovation program under grants 101003589 (RECOVER).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
No data referred in the manuscript.